nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ankylosing spondylitis—systemic lupus erythematosus	0.186	0.526	CtDrD
Sulfasalazine—rheumatoid arthritis—systemic lupus erythematosus	0.167	0.474	CtDrD
Sulfasalazine—PPARG—systemic lupus erythematosus	0.108	0.703	CbGaD
Sulfasalazine—PLA2G1B—Betamethasone—systemic lupus erythematosus	0.0607	0.248	CbGbCtD
Sulfasalazine—Sulfaphenazole—Dapsone—systemic lupus erythematosus	0.0571	0.342	CrCrCtD
Sulfasalazine—Sulfadiazine—Dapsone—systemic lupus erythematosus	0.0571	0.342	CrCrCtD
Sulfasalazine—Sulfapyridine—Dapsone—systemic lupus erythematosus	0.0527	0.316	CrCrCtD
Sulfasalazine—PTGS2—systemic lupus erythematosus	0.0456	0.297	CbGaD
Sulfasalazine—PLA2G1B—Dexamethasone—systemic lupus erythematosus	0.0353	0.144	CbGbCtD
Sulfasalazine—SLC46A1—Methotrexate—systemic lupus erythematosus	0.0284	0.116	CbGbCtD
Sulfasalazine—ABCG2—Leflunomide—systemic lupus erythematosus	0.0109	0.0443	CbGbCtD
Sulfasalazine—PTGS2—Dapsone—systemic lupus erythematosus	0.00846	0.0345	CbGbCtD
Sulfasalazine—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.00844	0.0345	CbGbCtD
Sulfasalazine—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.00742	0.0303	CbGbCtD
Sulfasalazine—PTGS2—Triamcinolone—systemic lupus erythematosus	0.00733	0.0299	CbGbCtD
Sulfasalazine—PTGS1—Dapsone—systemic lupus erythematosus	0.00714	0.0292	CbGbCtD
Sulfasalazine—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.00671	0.0274	CbGbCtD
Sulfasalazine—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0064	0.0261	CbGbCtD
Sulfasalazine—PTGS2—Betamethasone—systemic lupus erythematosus	0.00629	0.0257	CbGbCtD
Sulfasalazine—ABCC2—Cyclosporine—systemic lupus erythematosus	0.00562	0.023	CbGbCtD
Sulfasalazine—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.00538	0.022	CbGbCtD
Sulfasalazine—ABCG2—Cyclosporine—systemic lupus erythematosus	0.00508	0.0208	CbGbCtD
Sulfasalazine—CYP3A5—Dapsone—systemic lupus erythematosus	0.00429	0.0175	CbGbCtD
Sulfasalazine—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.00372	0.0152	CbGbCtD
Sulfasalazine—ABCC2—Dexamethasone—systemic lupus erythematosus	0.0037	0.0151	CbGbCtD
Sulfasalazine—PTGS2—Dexamethasone—systemic lupus erythematosus	0.00366	0.0149	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.00339	0.0138	CbGbCtD
Sulfasalazine—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00335	0.0137	CbGbCtD
Sulfasalazine—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00298	0.0122	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—systemic lupus erythematosus	0.00298	0.0121	CbGbCtD
Sulfasalazine—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00282	0.0115	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—systemic lupus erythematosus	0.00269	0.011	CbGbCtD
Sulfasalazine—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00185	0.00757	CbGbCtD
Sulfasalazine—TBXAS1—blood plasma—systemic lupus erythematosus	0.0012	0.043	CbGeAlD
Sulfasalazine—PLA2G1B—blood plasma—systemic lupus erythematosus	0.00101	0.0361	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—systemic lupus erythematosus	0.000765	0.0274	CbGeAlD
Sulfasalazine—ACAT1—nephron tubule—systemic lupus erythematosus	0.000741	0.0265	CbGeAlD
Sulfasalazine—ACAT1—kidney—systemic lupus erythematosus	0.000651	0.0233	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—systemic lupus erythematosus	0.00064	0.0229	CbGeAlD
Sulfasalazine—ACAT1—cortex of kidney—systemic lupus erythematosus	0.000634	0.0227	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—systemic lupus erythematosus	0.000601	0.383	CrCbGaD
Sulfasalazine—CHUK—connective tissue—systemic lupus erythematosus	0.00057	0.0204	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—systemic lupus erythematosus	0.000536	0.0192	CbGeAlD
Sulfasalazine—ACAT1—tendon—systemic lupus erythematosus	0.000526	0.0188	CbGeAlD
Sulfasalazine—SLCO1B1—blood plasma—systemic lupus erythematosus	0.000525	0.0188	CbGeAlD
Sulfasalazine—CHUK—skin of body—systemic lupus erythematosus	0.000515	0.0184	CbGeAlD
Sulfasalazine—PPARG—endothelium—systemic lupus erythematosus	0.00051	0.0183	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—systemic lupus erythematosus	0.000509	0.0182	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—systemic lupus erythematosus	0.000468	0.0167	CbGeAlD
Sulfasalazine—ACAT1—lung—systemic lupus erythematosus	0.000461	0.0165	CbGeAlD
Sulfasalazine—PLA2G1B—kidney—systemic lupus erythematosus	0.000456	0.0163	CbGeAlD
Sulfasalazine—PPARG—blood plasma—systemic lupus erythematosus	0.000453	0.0162	CbGeAlD
Sulfasalazine—TBXAS1—tendon—systemic lupus erythematosus	0.00044	0.0157	CbGeAlD
Sulfasalazine—ACAT1—nervous system—systemic lupus erythematosus	0.000427	0.0153	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—systemic lupus erythematosus	0.000426	0.0152	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—systemic lupus erythematosus	0.000417	0.0149	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—systemic lupus erythematosus	0.000417	0.0149	CbGeAlD
Sulfasalazine—ACAT1—central nervous system—systemic lupus erythematosus	0.000411	0.0147	CbGeAlD
Sulfasalazine—SLC7A11—kidney—systemic lupus erythematosus	0.0004	0.0143	CbGeAlD
Sulfasalazine—SLC46A1—tendon—systemic lupus erythematosus	0.000392	0.014	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—systemic lupus erythematosus	0.000387	0.0139	CbGeAlD
Sulfasalazine—TBXAS1—lung—systemic lupus erythematosus	0.000386	0.0138	CbGeAlD
Sulfasalazine—TBXAS1—nervous system—systemic lupus erythematosus	0.000357	0.0128	CbGeAlD
Sulfasalazine—IKBKB—skin of body—systemic lupus erythematosus	0.00035	0.0125	CbGeAlD
Sulfasalazine—TBXAS1—central nervous system—systemic lupus erythematosus	0.000344	0.0123	CbGeAlD
Sulfasalazine—CHUK—lung—systemic lupus erythematosus	0.000344	0.0123	CbGeAlD
Sulfasalazine—Balsalazide—PPARG—systemic lupus erythematosus	0.000333	0.212	CrCbGaD
Sulfasalazine—PLA2G1B—lung—systemic lupus erythematosus	0.000323	0.0116	CbGeAlD
Sulfasalazine—IKBKB—cortex of kidney—systemic lupus erythematosus	0.000321	0.0115	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—systemic lupus erythematosus	0.000321	0.0115	CbGeAlD
Sulfasalazine—SLC46A1—nervous system—systemic lupus erythematosus	0.000318	0.0114	CbGeAlD
Sulfasalazine—SLC46A1—central nervous system—systemic lupus erythematosus	0.000307	0.011	CbGeAlD
Sulfasalazine—PLA2G1B—nervous system—systemic lupus erythematosus	0.000299	0.0107	CbGeAlD
Sulfasalazine—PLA2G1B—central nervous system—systemic lupus erythematosus	0.000288	0.0103	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—systemic lupus erythematosus	0.000283	0.0101	CbGeAlD
Sulfasalazine—SLC7A11—lung—systemic lupus erythematosus	0.000283	0.0101	CbGeAlD
Sulfasalazine—Olsalazine—PPARG—systemic lupus erythematosus	0.000283	0.18	CrCbGaD
Sulfasalazine—PTGS1—endothelium—systemic lupus erythematosus	0.000273	0.00976	CbGeAlD
Sulfasalazine—CYP3A5—blood plasma—systemic lupus erythematosus	0.000269	0.00965	CbGeAlD
Sulfasalazine—IKBKB—tendon—systemic lupus erythematosus	0.000266	0.00954	CbGeAlD
Sulfasalazine—SLC7A11—nervous system—systemic lupus erythematosus	0.000262	0.00939	CbGeAlD
Sulfasalazine—PTGS2—endothelium—systemic lupus erythematosus	0.000261	0.00933	CbGeAlD
Sulfasalazine—SLC7A11—central nervous system—systemic lupus erythematosus	0.000252	0.00904	CbGeAlD
Sulfasalazine—PTGS1—blood plasma—systemic lupus erythematosus	0.000242	0.00867	CbGeAlD
Sulfasalazine—PPARG—connective tissue—systemic lupus erythematosus	0.000241	0.00864	CbGeAlD
Sulfasalazine—SLCO1B1—kidney—systemic lupus erythematosus	0.000238	0.00852	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—systemic lupus erythematosus	0.000235	0.00841	CbGeAlD
Sulfasalazine—IKBKB—lung—systemic lupus erythematosus	0.000234	0.00837	CbGeAlD
Sulfasalazine—PTGS2—blood plasma—systemic lupus erythematosus	0.000231	0.00829	CbGeAlD
Sulfasalazine—PPARG—skin of body—systemic lupus erythematosus	0.000218	0.0078	CbGeAlD
Sulfasalazine—IKBKB—nervous system—systemic lupus erythematosus	0.000216	0.00775	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—systemic lupus erythematosus	0.000214	0.00766	CbGeAlD
Sulfasalazine—IKBKB—central nervous system—systemic lupus erythematosus	0.000208	0.00746	CbGeAlD
Sulfasalazine—ABCC2—nephron tubule—systemic lupus erythematosus	0.000205	0.00735	CbGeAlD
Sulfasalazine—PPARG—kidney—systemic lupus erythematosus	0.000205	0.00735	CbGeAlD
Sulfasalazine—ALOX5—lung—systemic lupus erythematosus	0.000194	0.00694	CbGeAlD
Sulfasalazine—ABCC2—kidney—systemic lupus erythematosus	0.00018	0.00646	CbGeAlD
Sulfasalazine—ALOX5—nervous system—systemic lupus erythematosus	0.000179	0.00642	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—systemic lupus erythematosus	0.000176	0.00631	CbGeAlD
Sulfasalazine—ABCC2—cortex of kidney—systemic lupus erythematosus	0.000176	0.00629	CbGeAlD
Sulfasalazine—ALOX5—central nervous system—systemic lupus erythematosus	0.000173	0.00619	CbGeAlD
Sulfasalazine—PPARG—tendon—systemic lupus erythematosus	0.000166	0.00594	CbGeAlD
Sulfasalazine—PPARG—bone marrow—systemic lupus erythematosus	0.000161	0.00575	CbGeAlD
Sulfasalazine—ABCG2—nephron tubule—systemic lupus erythematosus	0.00015	0.00536	CbGeAlD
Sulfasalazine—ABCC2—tendon—systemic lupus erythematosus	0.000146	0.00522	CbGeAlD
Sulfasalazine—PPARG—lung—systemic lupus erythematosus	0.000145	0.00521	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—systemic lupus erythematosus	0.000141	0.0895	CrCbGaD
Sulfasalazine—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000139	0.00498	CbGeAlD
Sulfasalazine—PPARG—nervous system—systemic lupus erythematosus	0.000135	0.00482	CbGeAlD
Sulfasalazine—PPARG—central nervous system—systemic lupus erythematosus	0.00013	0.00464	CbGeAlD
Sulfasalazine—PTGS1—connective tissue—systemic lupus erythematosus	0.000129	0.00462	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—systemic lupus erythematosus	0.000123	0.00441	CbGeAlD
Sulfasalazine—CYP3A5—kidney—systemic lupus erythematosus	0.000122	0.00437	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—systemic lupus erythematosus	0.000119	0.0761	CrCbGaD
Sulfasalazine—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000119	0.00426	CbGeAlD
Sulfasalazine—PTGS1—skin of body—systemic lupus erythematosus	0.000116	0.00417	CbGeAlD
Sulfasalazine—PTGS2—skin of body—systemic lupus erythematosus	0.000111	0.00398	CbGeAlD
Sulfasalazine—PTGS1—kidney—systemic lupus erythematosus	0.00011	0.00393	CbGeAlD
Sulfasalazine—PTGS2—kidney—systemic lupus erythematosus	0.000105	0.00376	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—systemic lupus erythematosus	0.000103	0.00369	CbGeAlD
Sulfasalazine—Vismodegib—ALB—systemic lupus erythematosus	9.34e-05	0.0595	CrCbGaD
Sulfasalazine—ABCG2—lung—systemic lupus erythematosus	9.32e-05	0.00334	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—systemic lupus erythematosus	9.01e-05	0.00323	CbGeAlD
Sulfasalazine—PTGS1—tendon—systemic lupus erythematosus	8.86e-05	0.00317	CbGeAlD
Sulfasalazine—CYP3A5—lung—systemic lupus erythematosus	8.65e-05	0.0031	CbGeAlD
Sulfasalazine—PTGS2—tendon—systemic lupus erythematosus	8.47e-05	0.00303	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—systemic lupus erythematosus	8.2e-05	0.00294	CbGeAlD
Sulfasalazine—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	7.96e-05	0.0637	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	7.84e-05	0.0627	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	7.84e-05	0.0627	CbGdCrCtD
Sulfasalazine—PTGS1—lung—systemic lupus erythematosus	7.78e-05	0.00278	CbGeAlD
Sulfasalazine—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	7.66e-05	0.0613	CbGdCrCtD
Sulfasalazine—PTGS2—lung—systemic lupus erythematosus	7.43e-05	0.00266	CbGeAlD
Sulfasalazine—PTGS1—nervous system—systemic lupus erythematosus	7.2e-05	0.00258	CbGeAlD
Sulfasalazine—PTGS1—central nervous system—systemic lupus erythematosus	6.93e-05	0.00248	CbGeAlD
Sulfasalazine—PTGS2—nervous system—systemic lupus erythematosus	6.88e-05	0.00246	CbGeAlD
Sulfasalazine—SLC7A11—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	6.82e-05	0.0546	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Hydrocortisone—systemic lupus erythematosus	6.82e-05	0.0546	CbGdCrCtD
Sulfasalazine—PTGS2—central nervous system—systemic lupus erythematosus	6.63e-05	0.00237	CbGeAlD
Sulfasalazine—SLC7A11—Betamethasone—Methylprednisolone—systemic lupus erythematosus	6.43e-05	0.0515	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	6.43e-05	0.0515	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Dexamethasone—systemic lupus erythematosus	6.33e-05	0.0507	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Betamethasone—systemic lupus erythematosus	6.33e-05	0.0507	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Triamcinolone—systemic lupus erythematosus	6.19e-05	0.0495	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Triamcinolone—systemic lupus erythematosus	6.19e-05	0.0495	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisone—systemic lupus erythematosus	5.87e-05	0.047	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisone—systemic lupus erythematosus	5.87e-05	0.047	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisolone—systemic lupus erythematosus	5.73e-05	0.0459	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisolone—systemic lupus erythematosus	5.73e-05	0.0459	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	4.81e-05	0.0385	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	4.73e-05	0.0379	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	4.73e-05	0.0379	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	4.62e-05	0.037	CbGdCrCtD
Sulfasalazine—CHUK—Immune System—IFNA1—systemic lupus erythematosus	5.1e-06	0.0001	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EP300—systemic lupus erythematosus	5.08e-06	9.99e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TLR4—systemic lupus erythematosus	5.06e-06	9.96e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	4.97e-06	9.77e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—RASGRP1—systemic lupus erythematosus	4.97e-06	9.77e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD79A—systemic lupus erythematosus	4.95e-06	9.74e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD80—systemic lupus erythematosus	4.95e-06	9.73e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	4.91e-06	9.65e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	4.9e-06	9.63e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ALB—systemic lupus erythematosus	4.88e-06	9.6e-05	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—EP300—systemic lupus erythematosus	4.87e-06	9.58e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	4.86e-06	9.55e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—RXRA—systemic lupus erythematosus	4.85e-06	9.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	4.85e-06	9.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.83e-06	9.5e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—JUNB—systemic lupus erythematosus	4.83e-06	9.49e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PRL—systemic lupus erythematosus	4.81e-06	9.47e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.81e-06	9.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TLR9—systemic lupus erythematosus	4.79e-06	9.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40—systemic lupus erythematosus	4.77e-06	9.39e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	4.71e-06	9.27e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.71e-06	9.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CSK—systemic lupus erythematosus	4.71e-06	9.26e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTLA4—systemic lupus erythematosus	4.7e-06	9.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HMGB1—systemic lupus erythematosus	4.7e-06	9.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD80—systemic lupus erythematosus	4.67e-06	9.19e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—NOS3—systemic lupus erythematosus	4.67e-06	9.18e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	4.66e-06	9.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.64e-06	9.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNA1—systemic lupus erythematosus	4.62e-06	9.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQA1—systemic lupus erythematosus	4.57e-06	8.99e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—RASGRP1—systemic lupus erythematosus	4.5e-06	8.86e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD79A—systemic lupus erythematosus	4.49e-06	8.83e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD80—systemic lupus erythematosus	4.49e-06	8.83e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	4.49e-06	8.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PRL—systemic lupus erythematosus	4.45e-06	8.74e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—TGFB1—systemic lupus erythematosus	4.42e-06	8.69e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	4.41e-06	8.68e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—VDR—systemic lupus erythematosus	4.39e-06	8.64e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.38e-06	8.62e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PRL—systemic lupus erythematosus	4.37e-06	8.59e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—TYK2—systemic lupus erythematosus	4.35e-06	8.56e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NCF2—systemic lupus erythematosus	4.31e-06	8.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—LYN—systemic lupus erythematosus	4.28e-06	8.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQB1—systemic lupus erythematosus	4.27e-06	8.4e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTGS2—systemic lupus erythematosus	4.27e-06	8.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CSK—systemic lupus erythematosus	4.27e-06	8.4e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—EP300—systemic lupus erythematosus	4.25e-06	8.37e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.21e-06	8.28e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.21e-06	8.27e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.2e-06	8.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQA1—systemic lupus erythematosus	4.14e-06	8.15e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP9—systemic lupus erythematosus	4.13e-06	8.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	4.09e-06	8.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	4.05e-06	7.97e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL18—systemic lupus erythematosus	4.05e-06	7.97e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40LG—systemic lupus erythematosus	4.03e-06	7.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD8A—systemic lupus erythematosus	3.99e-06	7.85e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CSK—systemic lupus erythematosus	3.98e-06	7.83e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—NR3C1—systemic lupus erythematosus	3.95e-06	7.78e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TYK2—systemic lupus erythematosus	3.94e-06	7.76e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD4—systemic lupus erythematosus	3.93e-06	7.74e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EP300—systemic lupus erythematosus	3.92e-06	7.71e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NCF2—systemic lupus erythematosus	3.9e-06	7.68e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LYN—systemic lupus erythematosus	3.88e-06	7.63e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQB1—systemic lupus erythematosus	3.87e-06	7.62e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—JAK1—systemic lupus erythematosus	3.85e-06	7.57e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PPARG—systemic lupus erythematosus	3.85e-06	7.57e-05	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.83e-06	7.54e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.8e-06	7.48e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	3.79e-06	7.46e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.79e-06	7.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.78e-06	7.44e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD4—systemic lupus erythematosus	3.78e-06	7.43e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—RXRA—systemic lupus erythematosus	3.77e-06	7.42e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.75e-06	7.37e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD247—systemic lupus erythematosus	3.74e-06	7.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	3.74e-06	7.36e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—IL6—systemic lupus erythematosus	3.73e-06	7.34e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—VEGFA—systemic lupus erythematosus	3.71e-06	7.3e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CDKN1B—systemic lupus erythematosus	3.7e-06	7.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL18—systemic lupus erythematosus	3.67e-06	7.22e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40LG—systemic lupus erythematosus	3.66e-06	7.2e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NCF2—systemic lupus erythematosus	3.64e-06	7.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD8A—systemic lupus erythematosus	3.62e-06	7.12e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.6e-06	7.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2RA—systemic lupus erythematosus	3.6e-06	7.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD4—systemic lupus erythematosus	3.57e-06	7.02e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—C3—systemic lupus erythematosus	3.57e-06	7.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—JAK1—systemic lupus erythematosus	3.56e-06	6.99e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	3.55e-06	6.99e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—EP300—systemic lupus erythematosus	3.55e-06	6.99e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	3.52e-06	6.91e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.5e-06	6.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JAK1—systemic lupus erythematosus	3.49e-06	6.87e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ALB—systemic lupus erythematosus	3.46e-06	6.81e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.44e-06	6.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	3.44e-06	6.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD4—systemic lupus erythematosus	3.43e-06	6.74e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CDKN1A—systemic lupus erythematosus	3.41e-06	6.71e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TGFB1—systemic lupus erythematosus	3.41e-06	6.7e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CRP—systemic lupus erythematosus	3.39e-06	6.67e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—IL6—systemic lupus erythematosus	3.38e-06	6.65e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUNB—systemic lupus erythematosus	3.38e-06	6.65e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CCR5—systemic lupus erythematosus	3.37e-06	6.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.37e-06	6.63e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CDKN1B—systemic lupus erythematosus	3.35e-06	6.6e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.33e-06	6.56e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—IL6—systemic lupus erythematosus	3.33e-06	6.55e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.31e-06	6.52e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—NOS3—systemic lupus erythematosus	3.31e-06	6.51e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	3.28e-06	6.45e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2RA—systemic lupus erythematosus	3.26e-06	6.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TLR4—systemic lupus erythematosus	3.25e-06	6.4e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DRB1—systemic lupus erythematosus	3.25e-06	6.39e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EP300—systemic lupus erythematosus	3.25e-06	6.39e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—C3—systemic lupus erythematosus	3.23e-06	6.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	3.22e-06	6.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.21e-06	6.31e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—systemic lupus erythematosus	3.18e-06	6.26e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.12e-06	6.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PRL—systemic lupus erythematosus	3.11e-06	6.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CDKN1A—systemic lupus erythematosus	3.1e-06	6.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CRP—systemic lupus erythematosus	3.08e-06	6.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUNB—systemic lupus erythematosus	3.06e-06	6.03e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—systemic lupus erythematosus	3.03e-06	5.95e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD80—systemic lupus erythematosus	3e-06	5.9e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.97e-06	5.85e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	2.97e-06	5.85e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	2.97e-06	5.84e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TLR4—systemic lupus erythematosus	2.95e-06	5.8e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.95e-06	5.8e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DRB1—systemic lupus erythematosus	2.95e-06	5.79e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EP300—systemic lupus erythematosus	2.95e-06	5.79e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.91e-06	5.73e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—JUNB—systemic lupus erythematosus	2.86e-06	5.62e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PRL—systemic lupus erythematosus	2.82e-06	5.55e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD80—systemic lupus erythematosus	2.77e-06	5.45e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.76e-06	5.42e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	2.75e-06	5.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD80—systemic lupus erythematosus	2.72e-06	5.35e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.67e-06	5.26e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	2.64e-06	5.2e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PRL—systemic lupus erythematosus	2.63e-06	5.18e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—systemic lupus erythematosus	2.57e-06	5.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TYK2—systemic lupus erythematosus	2.53e-06	4.98e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—EP300—systemic lupus erythematosus	2.52e-06	4.95e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JAK1—systemic lupus erythematosus	2.49e-06	4.9e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.45e-06	4.82e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNG—systemic lupus erythematosus	2.37e-06	4.67e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR5—systemic lupus erythematosus	2.36e-06	4.64e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TYK2—systemic lupus erythematosus	2.34e-06	4.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.33e-06	4.57e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—C3—systemic lupus erythematosus	2.31e-06	4.54e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TYK2—systemic lupus erythematosus	2.3e-06	4.52e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—systemic lupus erythematosus	2.3e-06	4.52e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD4—systemic lupus erythematosus	2.29e-06	4.51e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JAK1—systemic lupus erythematosus	2.26e-06	4.44e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDKN1B—systemic lupus erythematosus	2.15e-06	4.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNG—systemic lupus erythematosus	2.15e-06	4.23e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—systemic lupus erythematosus	2.14e-06	4.21e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR5—systemic lupus erythematosus	2.14e-06	4.21e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—systemic lupus erythematosus	2.13e-06	4.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD4—systemic lupus erythematosus	2.12e-06	4.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.11e-06	4.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2—systemic lupus erythematosus	2.11e-06	4.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—JAK1—systemic lupus erythematosus	2.11e-06	4.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—systemic lupus erythematosus	2.1e-06	4.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	2.1e-06	4.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—C3—systemic lupus erythematosus	2.09e-06	4.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD4—systemic lupus erythematosus	2.08e-06	4.09e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—systemic lupus erythematosus	2.05e-06	4.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—F2—systemic lupus erythematosus	2.02e-06	3.98e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CCR5—systemic lupus erythematosus	2e-06	3.93e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1B—systemic lupus erythematosus	1.99e-06	3.91e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDKN1A—systemic lupus erythematosus	1.99e-06	3.91e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	1.97e-06	3.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1B—systemic lupus erythematosus	1.95e-06	3.84e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.95e-06	3.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD80—systemic lupus erythematosus	1.94e-06	3.82e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—systemic lupus erythematosus	1.93e-06	3.8e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—systemic lupus erythematosus	1.91e-06	3.76e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EP300—systemic lupus erythematosus	1.89e-06	3.72e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	1.88e-06	3.69e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—systemic lupus erythematosus	1.87e-06	3.69e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1A—systemic lupus erythematosus	1.84e-06	3.61e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—F2—systemic lupus erythematosus	1.84e-06	3.61e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—systemic lupus erythematosus	1.8e-06	3.55e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1A—systemic lupus erythematosus	1.8e-06	3.55e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD80—systemic lupus erythematosus	1.76e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EP300—systemic lupus erythematosus	1.75e-06	3.44e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	1.74e-06	3.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EP300—systemic lupus erythematosus	1.72e-06	3.37e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	1.69e-06	3.32e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	1.67e-06	3.28e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD80—systemic lupus erythematosus	1.64e-06	3.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TYK2—systemic lupus erythematosus	1.64e-06	3.22e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—systemic lupus erythematosus	1.64e-06	3.22e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	1.61e-06	3.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—systemic lupus erythematosus	1.61e-06	3.16e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—systemic lupus erythematosus	1.56e-06	3.07e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—EP300—systemic lupus erythematosus	1.56e-06	3.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—systemic lupus erythematosus	1.52e-06	2.99e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—systemic lupus erythematosus	1.5e-06	2.95e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	1.49e-06	2.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TYK2—systemic lupus erythematosus	1.49e-06	2.92e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	1.48e-06	2.9e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—systemic lupus erythematosus	1.46e-06	2.87e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	1.43e-06	2.82e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.39e-06	2.74e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TYK2—systemic lupus erythematosus	1.39e-06	2.73e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	1.37e-06	2.69e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—systemic lupus erythematosus	1.36e-06	2.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—systemic lupus erythematosus	1.36e-06	2.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	1.32e-06	2.61e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	1.31e-06	2.58e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—systemic lupus erythematosus	1.29e-06	2.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.29e-06	2.53e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.26e-06	2.48e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—systemic lupus erythematosus	1.25e-06	2.47e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	1.24e-06	2.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—systemic lupus erythematosus	1.24e-06	2.44e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—systemic lupus erythematosus	1.24e-06	2.43e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	1.23e-06	2.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EP300—systemic lupus erythematosus	1.22e-06	2.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—systemic lupus erythematosus	1.19e-06	2.34e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	1.18e-06	2.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—systemic lupus erythematosus	1.17e-06	2.3e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.17e-06	2.29e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.16e-06	2.28e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—systemic lupus erythematosus	1.14e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	1.14e-06	2.24e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—EP300—systemic lupus erythematosus	1.14e-06	2.23e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—systemic lupus erythematosus	1.12e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	1.12e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EP300—systemic lupus erythematosus	1.11e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.09e-06	2.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.09e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	1.07e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.06e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.05e-06	2.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EP300—systemic lupus erythematosus	1.03e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	9.79e-07	1.93e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.64e-07	1.9e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—systemic lupus erythematosus	8.99e-07	1.77e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—EP300—systemic lupus erythematosus	8.67e-07	1.7e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	8.14e-07	1.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—systemic lupus erythematosus	8.01e-07	1.58e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—systemic lupus erythematosus	7.27e-07	1.43e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—systemic lupus erythematosus	6.78e-07	1.33e-05	CbGpPWpGaD
